Exact Mass: 616.1998

Heme

C34H32FeN4O4 (616.1773)

Heme is the color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins. A heme or haem is a prosthetic group that consists of an iron atom contained in the center of a large heterocyclic organic ring called a porphyrin. Not all porphyrins contain iron, but a substantial fraction of porphyrin-containing metalloproteins have heme as their prosthetic subunit; these are known as hemoproteins. Protoheme ix, also known as ferroprotoheme or [fe(ppix)], is a member of the class of compounds known as metalloporphyrins. Metalloporphyrins are polycyclic compounds containing a porphyrin moiety and a metal atom. Protoheme ix can be found in a number of food items such as orange mint, cucumber, deerberry, and pear, which makes protoheme ix a potential biomarker for the consumption of these food products. Ferroheme, a complex of ferrous iron and a porphyrin, is an isosteric inhibitor of fatty acid binding to rat liver fatty acid binding protein[1][2]. Ferroheme, a complex of ferrous iron and a porphyrin, is an isosteric inhibitor of fatty acid binding to rat liver fatty acid binding protein[1][2].

trans-delta-Viniferin 3'-glucoside

C34H32O11 (616.1945)

trans-delta-Viniferin 3-glucoside is found in alcoholic beverages. trans-delta-Viniferin 3-glucoside is a constituent of the cell cultures of Vitis vinifera (wine grape) Constituent of the cell cultures of Vitis vinifera (wine grape). trans-delta-Viniferin 3-glucoside is found in alcoholic beverages and fruits.

trans-delta-Viniferin 3'-glucoside

C34H32O11 (616.1945)

trans-delta-Viniferin 3-glucoside is found in alcoholic beverages. trans-delta-Viniferin 3-glucoside is a constituent of the cell cultures of Vitis vinifera (wine grape) Constituent of the cell cultures of Vitis vinifera (wine grape). trans-delta-Viniferin 3-glucoside is found in alcoholic beverages and fruits.

Pallidol 3-glucoside

C34H32O11 (616.1945)

Pallidol 3-glucoside is found in alcoholic beverages. Pallidol 3-glucoside is isolated from Riesling wine. Isolated from Riesling wine. Pallidol 3-glucoside is found in alcoholic beverages.

Dimoracin

C38H32O8 (616.2097)

Dimoracin is found in fruits. Phytoalexin from Morus alba (white mulberry) infected with Fusarium solan

Candesartan N2-glucuronide

C30H28N6O9 (616.1918)

Candesartan N2-glucuronide is a metabolite of Candesartan. Candesartan n2-glucuronide belongs to the family of Acyclic Alkanes. These are acyclic hydrocarbons consisting only of n carbon atoms and m hydrogen atoms where m=2*n + 2.

Candesartan O-glucuronide

C30H28N6O9 (616.1918)

Candesartan O-glucuronide is a metabolite of candesartan. Candesartan is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. The prodrug candesartan cilexetil is marketed by AstraZeneca and Takeda Pharmaceuticals, commonly under the trade names Blopress, Atacand, Amias, and Ratacand. (Wikipedia)

Upunoside D

C34H32O11 (616.1945)

Senburiside II

C30H32O14 (616.1792)

Doliculide

C27H41IN2O6 (616.2009)

Upunoside C

C34H32O11 (616.1945)

kosinostatin

C33H32N2O10 (616.2057)

19396-03-3

C23H32N6O14 (616.1976)

13-O-p-Coumaroylplumieride

C30H32O14 (616.1792)

loasafolioside

C28H40O15 (616.2367)

dihydrocatalpol hexaacetate|Hexaacetyl-dihydrocatalpol

C27H36O16 (616.2003)

1,4,5-trihydroxy-7-methylnaphthalene-4-O-beta-xylopyranosyl-(1->4)-beta-xylopyranosyl-(1->6)-beta-glucopyranoside|diospyroside A

C27H36O16 (616.2003)

gnemonoside C

C34H32O11 (616.1945)

daphnine

C37H32N2O7 (616.2209)

(-)-epsilon-viniferin-12b-C-glucopyranoside|diptoindonesin

C34H32O11 (616.1945)

C34H32O11

C34H32O11 (616.1945)

(-)-ampelopsin F-11b-O-beta-glucopyranoside|cordifoloside A

C34H32O11 (616.1945)

7-<6-O-(alpha-L-rhamnopyranosyl)-2-O-(p-coumaroyl)-beta-D-glucopyranosyloxy>coumarin|7-[6-O-(alpha-L-rhamnopyranosyl)-2-O-(p-coumaroyl)-beta-D-glucopyranosyloxy]coumarin

C30H32O14 (616.1792)

gnemonoside D

C34H32O11 (616.1945)

Hexaacetyl-harpagid

C27H36O16 (616.2003)

(2Z)-2-methylbut-2-enoic acid (2R,5R,7R,8S,14aS)-5-(benzoyloxy)-5,6,7,8-tetrahydro-2,3-dimethoxy-7-methyl-1-oxospiro[1H,14H-benzo[1,8]cycloocta[1,2,3-cd][1,3]dioxolo[4,5-g]benzofuran-6,2-oxiran]-8-yl ester|Heteroclitin O

C34H32O11 (616.1945)

fragilide E

C28H37ClO13 (616.1923)

nui-inoalide B

C28H37ClO13 (616.1923)

kelletinin II

C33H28O12 (616.1581)

C30H32O14_Spiro[cyclopenta[c]pyran-7(1H),2(5H)-furan]-4-carboxylic acid, 1-(beta-D-glucopyranosyloxy)-4a,7a-dihydro-4-[(1S)-1-[[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]ethyl]-5-oxo-, methyl ester, (1S,4aS,7R,7aS)

C30H32O14 (616.1792)

methyl (1S,4aS,7aS)-4-[(1S)-1-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyethyl]-5-oxo-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[4a,7a-dihydro-1H-cyclopenta[c]pyran-7,2-furan]-4-carboxylate

C30H32O14 (616.1792)

Candesartan N2-Glucuronide

C30H28N6O9 (616.1918)

Dimoracin

C38H32O8 (616.2097)

trans-delta-Viniferin 3''-glucoside

C34H32O11 (616.1945)

trans-delta-Viniferin 3'''-glucoside

C34H32O11 (616.1945)

Pallidol 3-glucoside

C34H32O11 (616.1945)

polyoxin a

C23H32N6O14 (616.1976)

1-(PERFLUORO-N-OCTYL)TETRADECANE

C22H29F17 (616.1998)

5,10-di(4-pyridyl)-15,20-diphenylporphyrin

C42H28N6 (616.2375)

2-[(1E,3Z)-3-CHLORO-5-(1,1,3-TRIMETHYL-1,3-DIHYDRO-2H-BENZO[E]INDOL-2-YLIDENE)-1,3-PENTADIENYL]-1,1,3-TRIMETHYL-1H-BENZO[E]INDOLIUM PERCHLORATE

C35H34Cl2N2O4 (616.1896)

2-[2-[2-chloro-3-[2-(1,3,3-trimethylindol-1-ium-2-yl)ethenyl]inden-1-ylidene]ethylidene]-1,3,3-trimethylindole,perchlorate

C35H34Cl2N2O4 (616.1896)

4,4-bis(4,6-diphenyl-1,3,5-triazin-2-yl)biphenyl

C42H28N6 (616.2375)

Erio Green B

C31H33N2NaO6S2 (616.1678)

(2S,3S,4S,5R,6S)-6-[2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carbonyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C30H28N6O9 (616.1918)

3-[(1Z,4Z,10Z,14Z)-18-(2-carboxyethyl)-7,12-bis(ethenyl)-3,8,13,17-tetramethylporphyrin-21,22,23,24-tetraid-2-yl]propanoic acid;iron(6+)

C34H32FeN4O4+2 (616.1773)

[(2R,3S,4R,5S)-5-[(2R,3S,4S)-5-[4-[(2-amino-4-oxo-7,8-dihydro-3H-pteridin-6-yl)methylamino]phenyl]-2,3,4-trihydroxypentoxy]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

C23H33N6O12P (616.1894)

Ferroprotoporphyrin IX

C34H32FeN4O4-2 (616.1773)

Hematin

C34H32FeN4O4 (616.1773)

Ferroheme, a complex of ferrous iron and a porphyrin, is an isosteric inhibitor of fatty acid binding to rat liver fatty acid binding protein[1][2]. Ferroheme, a complex of ferrous iron and a porphyrin, is an isosteric inhibitor of fatty acid binding to rat liver fatty acid binding protein[1][2].

Ferriheme

C34H32FeN4O4+ (616.1773)

2-fluoro-N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide

C30H33FN2O7S2 (616.1713)

2-fluoro-N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide

C30H33FN2O7S2 (616.1713)

2-fluoro-N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide

C30H33FN2O7S2 (616.1713)

2-fluoro-N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide

C30H33FN2O7S2 (616.1713)

2-fluoro-N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide

C30H33FN2O7S2 (616.1713)

2-fluoro-N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide

C30H33FN2O7S2 (616.1713)

2-fluoro-N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide

C30H33FN2O7S2 (616.1713)

2-fluoro-N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide

C30H33FN2O7S2 (616.1713)

beta-D-Glucopyranuronic acid, 1-[5-[4-[(7-carboxy-2-ethoxy-1H-benzimidazol-1-yl)methyl][1,1-biphenyl]-2-yl]-2H-tetrazol-2-yl]-1-deoxy-

C30H28N6O9 (616.1918)

trans-delta-Viniferin 3-glucoside

C34H32O11 (616.1945)

Heme b

C34H32FeN4O4 (616.1773)

A metalloprotoporphyrin in which the four pyrrole nitrogens of the protoporphyrin moiety are coordinated to iron. It is the most abundant of the heme compounds.

ferroheme b

C34H32FeN4O4 (616.1773)

Heme b in which the iron has oxidation state +2.

2-(4-{2-[3-(3,5-dihydroxyphenyl)-4-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-6-yl]ethenyl}phenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C34H32O11 (616.1945)

methyl 5-ethenyl-4-(2-{[3-hydroxy-4-(methoxycarbonyl)-7-methyl-octahydrocyclopenta[c]pyran-6-yl]oxy}-2-oxoethyl)-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C28H40O15 (616.2367)

2-(3-{2-[3-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-5-yl]ethenyl}-5-hydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C34H32O11 (616.1945)

methyl 4-(2-{[(4r,4as,6s,7r,7as)-3-hydroxy-4-(methoxycarbonyl)-7-methyl-octahydrocyclopenta[c]pyran-6-yl]oxy}-2-oxoethyl)-5-ethenyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C28H40O15 (616.2367)

2-{4-[3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H32O11 (616.1945)

2-(hydroxymethyl)-6-{[4,6,14-trihydroxy-8,16-bis(4-hydroxyphenyl)tetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁵]hexadeca-2,4,6,10,12,14-hexaen-12-yl]oxy}oxane-3,4,5-triol

C34H32O11 (616.1945)

(1r,4as,6r,7r,7as)-6-[3-(3-hydroxybenzoyloxy)benzoyloxy]-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C30H32O14 (616.1792)

methyl (1s,4as,7r,7as)-4'-[(1s)-1-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}ethyl]-5'-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4a,7a-dihydro-1h-spiro[cyclopenta[c]pyran-7,2'-furan]-4-carboxylate

C30H32O14 (616.1792)

(1s,16r,17r,19r)-16-{[(2s)-5-acetyl-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-3,10-dihydroxy-17-methyl-4',5'-dihydro-1'h-18-oxaspiro[pentacyclo[15.2.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]icosane-19,2'-pyrrolo[2,3-b]pyrrole]-2,4(13),6,8,10,14-hexaene-5,12-dione

C33H32N2O10 (616.2057)

(2s,3z)-1-[(2s)-2-{[(2s,3s,4s)-2-amino-1,3,4-trihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}-2-[(3s,4r,5r)-3,4-dihydroxy-5-[4-hydroxy-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]oxolan-2-yl]acetyl]-3-ethylideneazetidine-2-carboxylic acid

C23H32N6O14 (616.1976)

anticancerstilbenoid pmv70p691-041

C34H32O11 (616.1945)

{"Ingredient_id": "HBIN016361","Ingredient_name": "anticancerstilbenoid pmv70p691-041","Alias": "NA","Ingredient_formula": "C34H32O11","Ingredient_Smile": "C1=CC(=CC=C1C2C(C3=C(O2)C=CC(=C3)C=CC4=CC(=CC(=C4)O)O)C5=CC(=CC(=C5)OC6C(C(C(C(O6)CO)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1445","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(2s,3r,4s,5s,6r)-2-{3-[(1e)-2-[(2s,3s)-3-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-5-yl]ethenyl]-5-hydroxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H32O11 (616.1945)

(16r,17r,19s)-16-{[(2s,4r,5s,6s)-5-acetyl-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-3,10-dihydroxy-17-methyl-4',5'-dihydro-1'h-18-oxaspiro[pentacyclo[15.2.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]icosane-19,2'-pyrrolo[2,3-b]pyrrole]-2,4(13),6,8,10,14-hexaene-5,12-dione

C33H32N2O10 (616.2057)

methyl (1s,4as,7r,7as)-4'-(1-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}ethyl)-5'-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4a,7a-dihydro-1h-spiro[cyclopenta[c]pyran-7,2'-furan]-4-carboxylate

C30H32O14 (616.1792)

(1s,16r,17r,19s)-16-{[(2s,4r,5s,6s)-5-acetyl-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-3,10-dihydroxy-17-methyl-4',5'-dihydro-1'h-18-oxaspiro[pentacyclo[15.2.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]icosane-19,2'-pyrrolo[2,3-b]pyrrole]-2,4(13),6,8,10,14-hexaene-5,12-dione

C33H32N2O10 (616.2057)

1,3,5-tris(4-hydroxybenzoyloxy)pentan-2-yl 4-hydroxybenzoate

C33H28O12 (616.1581)

4,5-dihydroxy-2-[(2-oxochromen-7-yl)oxy]-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-3-yl 3-(4-hydroxyphenyl)prop-2-enoate

C30H32O14 (616.1792)

2-[3-(3,5-dihydroxyphenyl)-6-hydroxy-2-(4-hydroxyphenyl)-4-[2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-7-yl]-6-(hydroxymethyl)oxane-3,4,5-triol

C34H32O11 (616.1945)

(1s,16r,17r,19r)-16-{[(2s,4r,5s,6s)-5-acetyl-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-3,10-dihydroxy-17-methyl-4',5'-dihydro-1'h-18-oxaspiro[pentacyclo[15.2.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]icosane-19,2'-pyrrolo[2,3-b]pyrrole]-2,4(13),6,8,10,14-hexaene-5,12-dione

C33H32N2O10 (616.2057)

(2s,3r,4s,5s,6r)-2-{4-[(2s,3s)-3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[(1e)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H32O11 (616.1945)

(2s,3r,4s,5s,6r)-2-{3-[(2s,3s)-5-[(1e)-2-(3,5-dihydroxyphenyl)ethenyl]-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-3-yl]-5-hydroxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H32O11 (616.1945)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(8r,9r,16r)-4,6,14-trihydroxy-8,16-bis(4-hydroxyphenyl)tetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁵]hexadeca-2,4,6,10,12,14-hexaen-12-yl]oxy}oxane-3,4,5-triol

C34H32O11 (616.1945)

6-[3-(3-hydroxybenzoyloxy)benzoyloxy]-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C30H32O14 (616.1792)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(1r,8r,9r,16r)-4,6,14-trihydroxy-8,16-bis(4-hydroxyphenyl)tetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁵]hexadeca-2,4,6,10,12,14-hexaen-12-yl]oxy}oxane-3,4,5-triol

C34H32O11 (616.1945)

methyl 4'-(1-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}ethyl)-5'-oxo-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4a,7a-dihydro-1h-spiro[cyclopenta[c]pyran-7,2'-furan]-4-carboxylate

C30H32O14 (616.1792)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(1r,8r,9s,16r)-4,6,14-trihydroxy-8,16-bis(4-hydroxyphenyl)tetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁵]hexadeca-2,4,6,10,12,14-hexaen-12-yl]oxy}oxane-3,4,5-triol

C34H32O11 (616.1945)

[(1s,2s,4s,5s,6r,10s)-5-(acetyloxy)-10-{[(2s,3r,4s,5r,6r)-3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-2-yl]methyl acetate

C27H36O16 (616.2003)

(2s,3r,4s,5s,6r)-4,5-dihydroxy-2-[(2-oxochromen-7-yl)oxy]-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C30H32O14 (616.1792)

(1s,4as,6s,7r,7as)-4-(methoxycarbonyl)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-6-yl (2s,3s,4r,6s)-2-hydroxy-6-methoxy-4-[(2e)-1-oxobut-2-en-2-yl]oxane-3-carboxylate

C28H40O15 (616.2367)

(3r,9s,11s,13r,14s,16s)-8,14-dihydroxy-3-[(4-hydroxy-3-iodophenyl)methyl]-16-isopropyl-4,9,11,13-tetramethyl-1-oxa-4,7-diazacyclohexadec-7-ene-2,5-dione

C27H41IN2O6 (616.2009)

(2s,3r,4s,5s,6r)-2-{[(2s,3s)-3-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)-4-[(1z)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H32O11 (616.1945)

2-[({3,4-dihydroxy-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl}oxy)methyl]-6-[(4,8-dihydroxy-6-methylnaphthalen-1-yl)oxy]oxane-3,4,5-triol

C27H36O16 (616.2003)

methyl 27-(acetyloxy)-8,13,15,20,22-pentahydroxy-29-methyl-11,18-dioxo-6-oxaheptacyclo[15.10.2.0¹,¹⁹.0³,¹⁶.0⁵,¹⁴.0⁷,¹².0²¹,²⁶]nonacosa-3(16),4,12,14,19,21,23,25,28-nonaene-7-carboxylate

C33H28O12 (616.1581)

[5-(acetyloxy)-10-{[3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-2-yl]methyl acetate

C27H36O16 (616.2003)

(2s,3r,4s,5s,6r)-2-{[(2r,3r)-3-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)-4-[(1e)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H32O11 (616.1945)

(2s,3r,4s,5s,6r)-2-{[(2s,3s)-3-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)-4-[(1e)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H32O11 (616.1945)

2-{[3-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)-4-[2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H32O11 (616.1945)

methyl (4s,5r,6s)-4-(2-{[(3r,4r,4as,6r,7r,7as)-3-hydroxy-4-(methoxycarbonyl)-7-methyl-octahydrocyclopenta[c]pyran-6-yl]oxy}-2-oxoethyl)-5-ethenyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate

C28H40O15 (616.2367)

(1s,10r,11s,13s,14s)-6-[(5s,6s,8s,8ar,10as)-1,5,8,8a-tetrahydroxy-10a-(hydroxymethyl)-6-methyl-9-oxo-5,6,7,8-tetrahydroxanthen-2-yl]-7,10,11,14-tetrahydroxy-13-methyl-2,16-dioxatetracyclo[9.3.2.0¹,¹⁰.0³,⁸]hexadeca-3,5,7-trien-9-one

C30H32O14 (616.1792)

[(1r,2s,3s,5s,6r,8s)-6-hydroxy-8-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-{[(4-hydroxy-3-methoxyphenyl)methoxy]methyl}oxan-2-yl]oxy}-9,10-dioxatetracyclo[4.3.1.0²,⁵.0³,⁸]decan-2-yl]methyl benzoate

C31H36O13 (616.2156)

methyl 27-(acetyloxy)-5,7,12,20,22-pentahydroxy-29-methyl-9,18-dioxo-14-oxaheptacyclo[15.10.2.0¹,¹⁹.0³,¹⁶.0⁶,¹⁵.0⁸,¹³.0²¹,²⁶]nonacosa-3(16),4,6(15),7,19,21,23,25,28-nonaene-13-carboxylate

C33H28O12 (616.1581)

(25e)-32,39-dimethoxy-9,27-dimethyl-2,15,17,20-tetraoxa-9,27-diazaoctacyclo[24.6.2.2³,⁶.2²¹,²⁴.1¹²,¹⁹.0⁵,¹⁰.0¹⁴,¹⁸.0³⁰,³⁴]nonatriaconta-1(33),3(39),5(10),6(38),12,14(18),19(37),21,23,25,28,30(34),31,35-tetradecaen-4-one

C37H32N2O7 (616.2209)

2-(3-{5-[2-(3,5-dihydroxyphenyl)ethenyl]-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-3-yl}-5-hydroxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C34H32O11 (616.1945)

(2r,3s,4s,5r,6s)-2-[(2r,3r)-3-(3,5-dihydroxyphenyl)-6-hydroxy-2-(4-hydroxyphenyl)-4-[(1e)-2-(4-hydroxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-7-yl]-6-(hydroxymethyl)oxane-3,4,5-triol

C34H32O11 (616.1945)

(2r,3s)-1,3,5-tris(4-hydroxybenzoyloxy)pentan-2-yl 4-hydroxybenzoate

C33H28O12 (616.1581)

[(1r,2s,3r,5r,6r,8s)-6-hydroxy-8-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[(4-hydroxybenzoyloxy)methyl]oxan-2-yl]oxy}-9,10-dioxatetracyclo[4.3.1.0²,⁵.0³,⁸]decan-2-yl]methyl 4-hydroxybenzoate

C30H32O14 (616.1792)

methyl (17s)-27-(acetyloxy)-8,13,15,20,22-pentahydroxy-29-methyl-11,18-dioxo-6-oxaheptacyclo[15.10.2.0¹,¹⁹.0³,¹⁶.0⁵,¹⁴.0⁷,¹².0²¹,²⁶]nonacosa-3(16),4,12,14,19,21,23,25,28-nonaene-7-carboxylate

C33H28O12 (616.1581)

(2r,3s,4s,5r,6s)-2-({[(2s,3r,4r,5r)-3,4-dihydroxy-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}methyl)-6-[(4,8-dihydroxy-6-methylnaphthalen-1-yl)oxy]oxane-3,4,5-triol

C27H36O16 (616.2003)

16-[(5-acetyl-4,5-dihydroxy-6-methyloxan-2-yl)oxy]-3,10-dihydroxy-17-methyl-4',5'-dihydro-1'h-18-oxaspiro[pentacyclo[15.2.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]icosane-19,2'-pyrrolo[2,3-b]pyrrole]-2,4(13),6,8,10,14-hexaene-5,12-dione

C33H32N2O10 (616.2057)

32,39-dimethoxy-9,27-dimethyl-2,15,17,20-tetraoxa-9,27-diazaoctacyclo[24.6.2.2³,⁶.2²¹,²⁴.1¹²,¹⁹.0⁵,¹⁰.0¹⁴,¹⁸.0³⁰,³⁴]nonatriaconta-1(33),3(39),5(10),6(38),12,14(18),19(37),21,23,25,28,30(34),31,35-tetradecaen-4-one

C37H32N2O7 (616.2209)

6-[1,5,8,8a-tetrahydroxy-10a-(hydroxymethyl)-6-methyl-9-oxo-5,6,7,8-tetrahydroxanthen-2-yl]-7,10,11,14-tetrahydroxy-13-methyl-2,16-dioxatetracyclo[9.3.2.0¹,¹⁰.0³,⁸]hexadeca-3,5,7-trien-9-one

C30H32O14 (616.1792)

(2s,3z)-1-[(2s)-2-{[(2s,3s,4s)-2-amino-1,3,4-trihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}-2-[(2r,3s,4r,5r)-3,4-dihydroxy-5-[4-hydroxy-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]oxolan-2-yl]acetyl]-3-ethylideneazetidine-2-carboxylic acid

C23H32N6O14 (616.1976)

(2s,3r,4s,5s,6r)-2-{4-[(1e)-2-[(2s,3s)-3-(3,5-dihydroxyphenyl)-4-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-6-yl]ethenyl]phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C34H32O11 (616.1945)